UPLOAD Filing
ACTUATE THERAPEUTICS, INC.
Date: July 31, 2025 · CIK: 0001652935 · Accession: 0000000000-25-008061
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288952
Letter
Re: Actuate Therapeutics, Inc. Registration Statement on Form S-1 Filed July 25, 2025 File No. 333-288952 Dear Daniel Schmitt:
July 31, 2025
Daniel Schmitt Chief Executive Officer Actuate Therapeutics, Inc. 1751 River Run, Suite 400 Fort Worth, TX 76107
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Janet Spreen, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 31, 2025 Daniel Schmitt Chief Executive Officer Actuate Therapeutics, Inc. 1751 River Run, Suite 400 Fort Worth, TX 76107 Re: Actuate Therapeutics, Inc. Registration Statement on Form S-1 Filed July 25, 2025 File No. 333-288952 Dear Daniel Schmitt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Janet Spreen, Esq. </TEXT> </DOCUMENT>